Case Report | Open Access
Pedunculated Angiomyofibroblastoma of the Vulva: Case Report and Review of the Literature
Angiomyofibroblastoma (AMFB) is a rare benign mesenchymal tumour that occurs almost exclusively in the vulvovaginal region of women but can also occur occasionally in the inguinoscrotal region of men. It is a well-circumscribed lesion that clinically is often thought to represent a Bartholin's gland cyst and usually does not form a pedunculated mass. To our knowledge, only five cases of vulvar AMFB with pedunculated mass have been reported in the English literature and all cases involving the labia majora and middle-aged women. We report the first case of pedunculated AMFB of the vulva occurring in a young woman of 21 years old and involving the left labia minora. After excluding the most common diseases, pedunculated AMFB should be part of differential diagnosis in the workup of any pedunculated vulvar mass even in young women with a lesion involving the labia minora. We reviewed the literature and summarized all reported cases.
Angiomyofibroblastoma (AMFB) is a rare benign mesenchymal tumor usually occurring in the vulvovaginal area of middle-aged women [1–3]. Histologically, the tumor is a well-circumscribed lesion composed of alternating hypo- and hypercellular areas with numerous delicate capillary-sized vessels . AMFB can be distinguished from the aggressive angiomyxoma by its circumscribed borders, the presence of plump stromal cells, and perivascular condensation of the stromal cells . Immunoreactivity for both desmin and vimentin is detected in almost all tumor cells, which also reveal estrogen and progesterone receptors . Clinically, AMFB shows a slowly growing mass which is often misdiagnosed as a Bartholin’s gland cyst and usually does not form a pedunculated mass . To our knowledge, only five cases of vulvar AMFB with pedunculated mass have been reported in the English literature and all cases involving the labia majora and middle-aged women [1, 7–10]. We report the first case of pedunculated AMFB of the vulva occurring in a young woman of 21 years old and involving the left labia minora.
2. Case Presentation
A 21-year-old woman came to our observation reporting the presence of a painless vulvar neoformation starting four years before, which had grown during the last months. She ignored the mass, despite its gradual enlargement during her disease course, and the complaint was of discomfort when seated and a localized burning sensation. Her personal history was noncontributory for previous surgery and laboratory data (emocrome, transaminase, sideremia, ferritin, creatinine, coagulation) showed no significant abnormalities. Clinical examination showed a pedunculated bilobulated neoformation of ten centimeters in diameter of tense elastic consistency, at the level of the left labia minora (Figure 1). On gynecological examination and vaginal ultrasound, the uterus and bilateral uterine adnexae showed no abnormalities. Inguinal lymph nodes were not swollen and tumor markers (cancer antigen (CA) 125, CA-19.9, CA-15.3, Alphafetoprotein and carcinoembryonic antigen) were negative. These markers were performed to exclude a concomitant malignancy in other locations. On ultrasound examination the mass revealed a well-demarcated soft tissue tumor with homogeneous echo and normal vascularity. In order to exclude a surgical disease, such as perineal hernia [11–13], the patient was evaluated by surgeons that, according with personal history, clinical examination, and ultrasonography, excluded a lesion of their interest.
The mass gave a clinical impression of vulvar fibroid, and a simple tumor excision was subsequently performed at the site of the stalk. During surgery, to exclude a malignancy lesion, a rapid intraoperative pathologic diagnosis of the tumor was performed, and it was reported as a benign soft lesion of the vulva. On gross examination, the lesion was well circumscribed, weighed 1230 gr, had a soft to firm consistency, and appeared homogeneously light gray to tan in color on the cut surface. No foci of hemorrhage nor necrosis was detected.
Microscopically, the mass consisted of fibroconnective tissue with abundant vessels of various wall thickness (Figures 2(a) and 2(b)). No mitotic or atypical cells were seen, and the stroma was edematous. In immunohistochemistry, tumor cells were strongly positive for desmin and estrogen receptors (Figures 3(a) and 3(b)) and negative for -smooth muscle actin, S-100 protein, cytokeratin, and CD34. All these features were in favour of the diagnosis of AMFB. Surgical margins of the lesion were clear, and the pedicle was not involved by the tumor.
Currently the patient is in followup for two years with clinical examination every six months with no evidence of recurrence.
This distinctive tumor was first delineated by Fletcher et al. in 1992 who described 10 cases involving the vulva  with only one case reporting a large pedunculated mass. There is a marked predilection for the female genital tract, predominantly the vulva, although rare cases have also been reported to arise in the scrotum and the inguinal area in males [8, 14]. The female patients have an average age of 45.8 years . They usually complain of a painless mass that has been present from a few weeks to up to 13 years . Clinically, these tumors are frequently thought to be a Bartholin gland cyst, although a preoperative differential diagnosis includes labial cysts, inguinal hernia, leiomyoma, and mesenchymal tumors such as lipoma and liposarcoma .
On gross examination they are typically well circumscribed and ranged from 0.5 to 12 cm. They have a soft to rubbery consistency and a bulging, pink, and somewhat lobulated sectioned surface . Microscopic examination confirms the well-demarcated nature of the lesion and shows alternating hypercellular and hypocellular edematous regions with abundant blood vessels. There is minimal nuclear atypicality, and mitotic figures are rare. The cells tend to cluster around blood vessels, sometime forming compact foci . Adipocytes can be sparsely scattered within the neoplasm and in rare cases fat predominates; these tumors have been classified as the “lipomatous” variant of angiomyofibroblastoma . The angiomyofibroblastoma can be distinguished from the aggressive angiomyxoma by its circumscribed borders, the presence of plump stromal cells that are occasionally overtly epithelioid, and perivascular condensation of the stromal cells . A single case of a malignant transformation of an AMFB in angiomyofibrosarcoma has been reported . In that tumor, areas of typical AMFB merged imperceptibly with high-grade sarcoma resembling a myxoid malignant fibrous histiocytoma.
Immunohistochemical stains show uniform staining for vimentin and staining of a variable number of cells for desmin in most cases. The tumor cells also show variable expression for muscle actin and smooth muscle actin and are frequently positive for estrogen and progesterone receptors . The expression of estrogen and progesterone receptors suggests that it might arise as a neoplastic proliferation of hormonally responsible mesenchymal cells . Some tumors have also stained for CD34, although some authors question whether these CD34 positive tumors might present fibroepithelial polyps, which are frequently positive for this marker .
The tumor usually exists as a sharply circumscribed mass in the subcutaneous tissue of the vulva and usually does not form a pedunculated mass, which represents an exceptional event . To our knowledge, only five cases of pedunculated AMFB of the vulva have been reported in the English literature [1, 7–10].
All cases are reported in Table 1. All patients underwent simple excision. The mean age of patients was 46.4 years with a range of 41–50 years. The lesion always involved the labia majora. The average size of the pedunculated AMFB was of 14.2 × 13.6 centimeters in diameter (range 4 to 23 cm). Except for one case, the presence of the lesion had existed for several years. The real problem is the preoperative clinical diagnosis, as the vulvar AMFB is a rare event revealed only by histological examination after surgery. All patients had an uneventful postoperative course, and the mean followup was of 20 months (ranging from 8 months to 3 years) with no recurrence.
Table 2 shows immunohistochemical staining for the most common antibodies in the AMFB. Almost all tumor cells were strongly positive for vimentin and desmin, but uniformly negative for cytokeratin and S-100 protein. Not all tumor cells were negative for -smooth muscle actin and CD34. Staining for estrogen and progesterone receptors was observed in the nucleus of all tumor cells.
|+ = positive; − = negative; ± = low positive; U = unchecked; e-R = estrogen receptor; p-R = progesterone receptor; S-100 p = S-100 protein; ASMA = -smooth muscle actin.|
Given the data reported in the literature on the pedunculated AMFB of the vulva, our case is the first concerning a young woman of 21 years old and involving the labia minora. The patient underwent simple excision with clear margin of the lesion and currently is in followup performing clinical examination every six months for two years with no recurrence.
This paper aims to emphasize that, after excluding the most common vulvar diseases, the appearance of a pedunculated AMFB should be part of differential diagnosis in the workup of any pedunculated vulvar mass even in young women with a lesion involving the labia minora. The treatment of choice is a surgical excision with clear margins, which is resolutive as demonstrated by reported cases in the literature.
- I. H. Hsu, T. C. Chang, C. T. Wu, R. J. Chen, and S. N. Chow, “Angiomyofibroblastoma of the vulva,” Journal of the Formosan Medical Association, vol. 103, no. 6, pp. 467–471, 2004.
- R. Laiyemo, S. Disu, G. Vijaya, and B. Wise, “Post-menopausal vaginal angiomyofibroblastoma: a case report,” Archives of Gynecology and Obstetrics, vol. 273, no. 2, pp. 129–130, 2005.
- M. Varras, C. Akrivis, A. Demou, E. Kitsiou, and N. Antoniou, “Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: clinicopathologic analysis of a case and review of the literature,” International Journal of Gynecological Cancer, vol. 16, no. 2, pp. 581–585, 2006.
- M. R. Nucci and C. D. M. Fletcher, “Vulvovaginal soft tissue tumours: update and review,” Histopathology, vol. 36, no. 2, pp. 97–108, 2000.
- G. P. Nielsen and R. H. Young, “Mesenchymal tumors and tumor-like lesions of the female genital tract: a selective review with emphasis on recently described entities,” International Journal of Gynecological Pathology, vol. 20, no. 2, pp. 105–127, 2001.
- H. Horiguchi, M. Matsui-Horiguchi, M. Fujiwara et al., “Angiomyofibroblastoma of the vulva: report of a case with immunohistochemical and molecular analysis,” International Journal of Gynecological Pathology, vol. 22, no. 3, pp. 277–284, 2003.
- M. Omori, H. Toyoda, T. Hirai, T. Ogino, and S. Okada, “Angiomyofibroblastoma of the vulva: a large pedunculated mass formation,” Acta Medica Okayama, vol. 60, no. 4, pp. 237–242, 2006.
- C. D. M. Fletcher, W. Y. W. Tsang, C. Fisher, K. C. Lee, and J. K. C. Chan, “Angiomyofibroblastoma of the vulva: a benign neoplasm distinct from aggressive angiomyxoma,” American Journal of Surgical Pathology, vol. 16, no. 4, pp. 373–382, 1992.
- S. Barat, S. Tirgar-Tabari, and S. Shafaee, “Angiomyofibroblastoma of the vulva,” Archives of Iranian Medicine, vol. 11, no. 2, pp. 224–226, 2008.
- K. Nagai, K. Aadachi, and H. Saito, “Huge pedunculated angiomyofibroblastoma of the vulva,” International Journal of Clinical Oncology, vol. 15, no. 2, pp. 201–205, 2010.
- A. Preiß, B. Herbig, and A. Dörner, “Primary perineal hernia: a case report and review of the literature,” Hernia, vol. 10, no. 5, pp. 430–433, 2006.
- A. Mohta and K. B. Satish, “Congenital perineal hernia: report of a case,” Surgery Today, vol. 34, no. 7, pp. 630–631, 2004.
- A. A. Singer, “Ultrasonographic diagnosis of perineal hernia,” Journal of Ultrasound in Medicine, vol. 13, no. 12, pp. 987–988, 1994.
- D. M. Ockner, H. Sayadi, P. E. Swanson, J. H. Ritter, and M. R. Wick, “Genital angiomyofibroblastoma. Comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue,” American Journal of Clinical Pathology, vol. 107, no. 1, pp. 36–44, 1997.
- N. Tochika, A. Takeshita, H. Sonobe, M. Matsumoto, M. Kobayashi, and K. Araki, “Angiomyofibroblastoma of the vulva: report of a case,” Surgery Today, vol. 31, no. 6, pp. 557–559, 2001.
- W. B. Laskin, J. F. Fetsch, and F. A. Tavassoli, “Angiomyofibroblastoma of the female genital tract: analysis of 17 cases including a lipomatous variant,” Human Pathology, vol. 28, no. 9, pp. 1046–1055, 1997.
- S. R. Granter, M. R. Nucci, and C. D. M. Fletcher, “Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases,” Histopathology, vol. 30, no. 1, pp. 3–10, 1997.
- G. P. Nielsen, R. H. Young, G. R. Dickersin, and A. E. Rosenberg, “Angiomyofibroblastoma of the vulva with sarcomatoms transformation (“angiomyofibrosarcoma”),” American Journal of Surgical Pathology, vol. 21, no. 9, pp. 1104–1108, 1997.
Copyright © 2011 Luca Giannella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.